Registry collecting data on adults with acute lymphoblastic leukemia
Collects information on diagnosis, treatment and outcomes in adults with acute lymphoblastic leukemia.
Plain-language title generated from the registry record
Registry title: GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
Key facts
- Where
- Graz, Leoben, Linz, Sankt Pölten, and Vienna, AustriaSee the 5 sites
Where in Austria
- Universitätsklinikum GrazGraz, AustriaTaking people
- LKH Hochsteiermark-LeobenLeoben, AustriaTaking people
- Ordensklinikum Linz ElisabethinenLinz, AustriaTaking people
- Universitätsklinikum St. PöltenSankt Pölten, AustriaTaking people
- Hanusch-Krankenhaus WienVienna, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Goethe University
- Trial code
- NCT02872987
- Record updated
- 5 August 2026
- Original description
The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.Read full original descriptionShow less
Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult ALL Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
The GMALL registry serves the purpose of ALL research and quality assurance. The Registry collects data about diagnostics, treatment and outcome of Adult ALL Patients in the clinical routine, whether or not the patient is treated within a clinical trial.
Inclusion: Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols; Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols; Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols; Age minimum 18 yrs.